(4-traders.com) Bio-Techne Corporation Acquires Access to B-MoGen Biotechnologies' Gene Editing Technology MINNEAPOLIS, May 4, 2016 / PRNewswire/ --Bio-Techne Corporation (NASDAQ: TECH) and B-MoGen Biotechnologies, Inc. announced today that Bio-Techne has made a seed investment in B-MoGen and the parties have entered into...http://www.4-traders.com/BIO-TECHNE-CORP-18468619/news/Bio-Techne-Acquires-Access-to-B-MoGen-Biotechnologies-rsquo-Gene-Editing-Technology-22295653/